Bloom Science

KOBIOLABS

This company develops microbiome-derived therapeutics and live biotherapeutic products for patients with immune, metabolic, neurological and gastrointestinal diseases.

Vedanta Biosciences

This company develops microbiome-based oral therapies using bacterial consortia to treat patients with gastrointestinal and immune-mediated diseases.

Human Biome

This biotechnology firm develops gut microbiota-based biotherapeutics and fecal microbiota transplantation preparations for medical professionals treating gastrointestinal infections and antibiotic resistance.

BEO Therapeutics

This company develops oral microbiome therapies to treat patients with gouty arthritis and chronic kidney disease by reducing metabolic waste products.

Scioto Biosciences

This company develops live bacterial therapeutics and delivery platforms to treat patients with autism, gastrointestinal disorders and neonatal intestinal conditions.

EnteroBiotix

This biopharmaceutical company develops orally administered microbial therapeutics for patients with gastrointestinal diseases, including irritable bowel syndrome and blood cancers.

Fable Therapeutics

The company develops protein-engineered biologics using machine learning to treat patients with obesity and metabolic diseases.

Enterbiotix

This company develops orally administered microbiome therapeutics to treat patients with gastrointestinal conditions including irritable bowel syndrome and liver cirrhosis.